Richardson T, Scheid C, Herling M, Frenzel LP, et al. Post-transplant-cyclophosphamide and short-term Everolimus as graft-versus-host-prophylaxis in patients with relapsed/refractory lymphoma and myeloma-Final results of the phase II OCTET-EVER trial. Eur J Haematol 2024 Apr 14. doi: 10.1111/ejh.14210.
PMID: 38616351